Information
-
Trademark
-
79066961
-
Serial Number
79066961
-
Registration Number
3742666
-
International Classifications
-
Filing Date
March 13, 2009
15 years ago
-
Registration Date
January 26, 2010
14 years ago
-
Transaction Date
October 12, 2019
5 years ago
-
Status Date
March 13, 2019
5 years ago
-
Published for Opposition Date
November 10, 2009
15 years ago
-
Location Date
January 26, 2010
14 years ago
-
Status Code
404
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
WIENER, MICHAEL A
-
Attorney Name
CYNTHIA C. WEBER
Law Office Assigned Location Code
L80
-
Owners
Mark Drawing Code
3000
Mark Identification
ARK THERAPEUTICS
Case File Statements
- CC0000: The color(s) blue and yellow is/are claimed as a feature of the mark.
- D10000: "THERAPEUTICS"
- DM0000: The mark consists of an outer arc in the color blue and a concentric inner arc in the color yellow. To the right of the arcs appears the term "ARK" in the color blue over the term "THERAPEUTICS" also in blue.
- GS0011: Diagnostic protein preparations for use in science, scientific diagnostics and industry; diagnostic preparations of genes for use in science, scientific diagnostics and industry
- GS0051: Pharmaceutical preparations for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; pharmaceutical preparations for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; pharmaceutical preparations to promote or suppress angiogenesis and enhance blood flow; pharmaceutical preparations for increasing the efficiency of muscle cell energy production; therapeutic agents for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; therapeutic agents for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; therapeutic agents to promote or suppress angiogenesis and enhance blood flow; therapeutic agents for increasing the efficiency of muscle cell energy production; diagnostic preparations for medical purposes; protein preparations for clinical or medical laboratory use, namely for targeting therapeutic agents to specific sites; medical dressings; surgical dressings; burn dressings; wound dressings; absorbent wound and burn dressings in the nature of pads; foot and hand dressings for medical purposes; fluid handling foot and hand dressings for medical purposes; preparations of genes for therapeutics purposes namely for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; preparations of genes for therapeutic purposes namely for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; preparations of genes for therapeutic purposes namely to promote or suppress angiogenesis and enhance blood flow; preparations of genes for therapeutic purposes namely for increasing the efficiency of muscle cell energy production
- GS0101: Boots and gloves for orthopaedic and medical purposes; boots and gloves for medical purposes with the ability to handle wound fluid; boots and gloves for medical use and absorbent filters, liners and inserts for use therewith; filters, soles and absorbent inserts for socks, boots and gloves for medical purposes, namely, for the treatment of wounds and burns; foot and hand dressings for medical purposes, namely, for the treatment of wounds and burns; parts and fittings for all the aforesaid goods
- GS0421: Scientific, medical and clinical research, all in the field of the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting, prevention of stenosis, increasing the efficiency of muscle cell energy production and promoting or suppressing angiogenesis and enhancing blood flow; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances; scientific, medical and clinical research in the field of gene therapy; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances for use in the field of gene therapy; advisory services relating to the aforesaid services; scientific, medical and clinical research in the field of genes and genetics; medical and scientific research, namely, conducting gene therapy trials; provision of information relating to the above
Case File Event Statements
-
10/11/2019 - 5 years ago
30 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Type: DENC
-
10/11/2019 - 5 years ago
29 - DEATH OF INTERNATIONAL REGISTRATION
Type: DETH
-
6/16/2017 - 7 years ago
28 - TOTAL INVALIDATION PROCESSED BY THE IB
Type: INNT
-
5/11/2017 - 7 years ago
27 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Type: INTS
-
5/11/2017 - 7 years ago
26 - INVALIDATION PROCESSED
Type: INPC
-
5/2/2017 - 7 years ago
25 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Type: INTR
-
9/2/2016 - 8 years ago
24 - CANCELLED SECTION 71
Type: C71T
-
2/7/2013 - 11 years ago
23 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
5/24/2010 - 14 years ago
22 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
5/24/2010 - 14 years ago
21 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
4/26/2010 - 14 years ago
20 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
1/26/2010 - 14 years ago
19 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
11/10/2009 - 15 years ago
18 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/21/2009 - 15 years ago
17 - NOTICE OF PUBLICATION
Type: NPUB
-
10/7/2009 - 15 years ago
16 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
10/5/2009 - 15 years ago
15 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/12/2009 - 15 years ago
14 - AMENDMENT FROM APPLICANT ENTERED
Type: ACEC
-
9/12/2009 - 15 years ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/12/2009 - 15 years ago
12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
9/12/2009 - 15 years ago
11 - ASSIGNED TO LIE
Type: ALIE
-
9/9/2009 - 15 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/18/2009 - 15 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
6/10/2009 - 15 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
6/10/2009 - 15 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
6/10/2009 - 15 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
6/9/2009 - 15 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/5/2009 - 15 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
4/28/2009 - 15 years ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
4/24/2009 - 15 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
4/23/2009 - 15 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR